Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types

Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types

Siglec-9, a cell surface transmembrane receptor mainly expressed on B cells, CD56+ NK cells, and CD4+ and CD8+ T cells, is strongly related to the tumor immune microenvironment. However, the expression pattern of Siglec-9 and its prognostic potential have not been investigated in a pan-cancer perspe...

Full description

Bibliographic Details
Main Authors: Yuliang Wu, Wei Huang, Yutong Xie, Chunyan Wang, Ning Luo, Yingying Chen, Liefu Wang, Zhongping Cheng, Zhengliang Gao, Shupeng Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Molecular Biosciences
Subjects:
Siglec-9
the Cancer Genome Atlas
immune infiltration
pan-cancer
LGG
GSEA
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.743515/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2022.743515/full

Similar Items